Explore the frontier of medical innovation with the latest Industry Focus eBook on Cell & Gene Therapy.
This exclusive eBook brings together the latest in research, expert commentary, and personal stories that show how cell and gene therapy is making a real difference. You’ll find everything from firsthand accounts of CAR T-cell breakthroughs to exciting developments in single-cell analysis and CRISPR-based diagnostics—all in one place.
Download the eBook
Whether you’re working in the lab, seeing patients, or supporting innovation behind the scenes, this collection offers a clear look at how new tools and therapies are changing how we detect, treat, and even prevent disease. Sponsored by Sphere Bio, it also spotlights technologies pushing the field forward, from faster antibody discovery to smarter cell therapy validation and fresh insights into immune aging.
Download your copy and see how cell and gene therapy is not just advancing medicine, it’s reshaping what’s possible.
About Sphere Bio
Our vision
Our philosophy is simple. We combine our knowledge and resources to help you find rare and valuable biological variants, while helping you to save time, reduce costs and stay a step ahead of the competition.
Our novel single cell analysis systems offer the rapid screening and characterization of single cells. These systems are underpinned by our patented picodroplet technology, specifically designed to increase your chances of finding that rare ‘one-in-a-billion’ molecule or cell that could be an industry blockbuster.
We understand that time is of the essence. That’s why our technologies boost throughput and assay sensitivity across a range of applications. Most importantly, our flexible systems evolve alongside your changing research needs, providing an adaptable platform that helps you to meet your goals.
Our history
Founded in 2010, Sphere Bio is an established Life Sciences company, originally spun out from the University of Cambridge. We initially developed 25 patented products – biochips and specialist chemicals – which currently assist hundreds of customers globally with their research.
Traditionally, we focused on producing novel biochip systems and providing R&D services. We have since extended our expertise and are developing a technology platform that enables discovery in a range of growing markets through single cell analysis. Our systems make the development of new biopharmaceuticals faster and more cost-effective, improve monoclonal antibody screening, cell line development, and overall research efficiency in a number of other applications including single cell diagnostics, prognostics and single cell genome editing.
The Cyto-Mine® Single Cell Analysis System is our flagship product – the first integrated, benchtop system to automatically analyse, sort and dispense millions of individual cells in just a single day.
Our partnerships
We value and are always open to discussing new collaborative, successful and innovative academic and industry partnerships to further develop and improve our single cell technologies.
Our Technology Access Programmes and Collaborative Services exist to enable academic researchers and companies alike to tap into our application-specific expertise through direct partnerships.
Sphere Bio. We work small so you can think big.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.